De Greef Roderick's Form 4 filing
Biolife Solutions Inc (BLFS) · filed Nov 13, 2025
- Accession no.
- 0001628280-25-052129
- Filed
- Nov 13, 2025
- Trade date
- Nov 11-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.58M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| De Greef RoderickCIK 0001241181 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2025 | Common Stock | SSaleDisposed | −35,417 | $26.15 | −$926,154.55 | 454,581 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −33,418 | $25.88 | −$864,857.84 | 421,163 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −31,165 | $25.33 | −$789,409.45 | 389,998 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.